Detalhe da pesquisa
1.
Allogeneic transplantation in advanced cutaneous T-cell lymphomas (CUTALLO): a propensity score matched controlled prospective study.
Lancet
; 401(10392): 1941-1950, 2023 06 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37105210
2.
Macrophage-derived CXCL9 and CXCL11, T-cell skin homing, and disease control in mogamulizumab-treated CTCL patients.
Blood
; 139(12): 1820-1832, 2022 03 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34905599
3.
Targeting CCR4 with mogamulizumab in refractory CD3-CD4+ lymphocytic-variant hypereosinophilic syndrome.
Haematologica
; 2024 Feb 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38328856
4.
Two cases of dupilumab-responsive Kimura disease.
Clin Exp Dermatol
; 49(5): 502-506, 2024 Apr 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38149974
5.
Plasma cell-directed therapies in monoclonal gammopathy-associated scleromyxedema.
Blood
; 135(14): 1101-1110, 2020 04 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32027747
6.
Mogamulizumab induces long-term immune restoration and reshapes tumour heterogeneity in Sézary syndrome.
Br J Dermatol
; 186(6): 1010-1025, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35041763
7.
Treatment strategies and safety of rechallenge in the setting of immune checkpoint inhibitors-related myositis: a national multicentre study.
Rheumatology (Oxford)
; 60(12): 5753-5764, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33725115
8.
Persistent deficiency of mucosal-associated invariant T cells during dermatomyositis.
Rheumatology (Oxford)
; 59(9): 2282-2286, 2020 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31846040
9.
Lupus Erythematosus Tumidus Mimicking Primary Cutaneous Marginal Zone B-cell Lymphoma.
Acta Derm Venereol
; 100(15): adv00229, 2020 Aug 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-32556349
10.
Mogamulizumab-induced Mucocutaneous Lichenoid Reaction: A Case Report and Short Review.
Acta Derm Venereol
; 100(10): adv00158, 2020 May 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-32449779
11.
Heterogeneity of PD-L1 expression and CD8 tumor-infiltrating lymphocytes among subtypes of cutaneous adnexal carcinomas.
Cancer Immunol Immunother
; 68(6): 951-960, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30953116
12.
Involvement of the CD39/CD73/adenosine pathway in T-cell proliferation and NK cell-mediated antibody-dependent cell cytotoxicity in Sézary syndrome.
Blood
; 139(17): 2712-2716, 2022 04 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35051270
13.
Clinical, pathological, and molecular features of myelodysplasia cutis.
Blood
; 139(8): 1251-1253, 2022 02 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34788403
14.
Failure of second challenge with mogamulizumab in C-C chemokine receptor 4-positive cutaneous T-cell lymphoma.
Br J Dermatol
; 190(6): 920-921, 2024 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38390970
15.
Evolution of patients with Sézary syndrome after mogamulizumab discontinuation for any cause except progression: a multicenter retrospective study (Moga-stop study).
Br J Dermatol
; 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38660811
16.
Myopathy related to chronic Graft-Versus-Host Disease: From clinic to histological & immunological characterization by imaging mass cytometry.
Am J Hematol
; 99(6): 1187-1191, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38511942
17.
Risk factors for death and survival in paraneoplastic pemphigus associated with hematologic malignancies in adults.
J Am Acad Dermatol
; 80(6): 1544-1549, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30981429
18.
Efficacy and safety of etanercept for postoperative pyoderma gangrenosum after infliximab serum sickness.
Dermatol Ther
; 32(1): e12774, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30341800
19.
Severe relapses of cutaneous T-cell lymphoma after treatment of chronic graft-versus-host disease with ruxolitinib.
J Eur Acad Dermatol Venereol
; 38(1): e32-e34, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37561935
20.
Impact of blood tumour clone frequency on time to next treatment in mycosis fungoides.
J Eur Acad Dermatol Venereol
; 2024 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38469982